Acrivon Therapeutics, Inc. · NASDAQ:ACRV
Acrivon Therapeutics, Inc. shareholders
As of Jun 30, 2026, 45 institutions reported holding Acrivon Therapeutics, Inc., 49.9% of its shares. Largest: Ra Capital Management, L.P., Sands Capital Alternatives, LLC and Acadian Asset Management LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Acrivon Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Ra Capital Management, L.P. | 12.2M | 28.5% | +3.89M | Aug 14, 2026 |
| Sands Capital Alternatives, LLC | 2.29M | 5.3% | +167K | Aug 13, 2026 |
| Acadian Asset Management LLC | 1.17M | 2.7% | +319K | Aug 13, 2026 |
| Vanguard | 1.14M | 2.7% | +307K | Aug 13, 2026 |
| Wellington | 888K | 2.1% | no change | Aug 14, 2026 |
| Renaissance Technologies | 759K | 1.8% | +423 | Aug 13, 2026 |
| Two Sigma | 641K | 1.5% | +252K | Aug 14, 2026 |
| Marshall Wace, LLP | 532K | 1.2% | −28,580 | Aug 13, 2026 |
| Bridgeway Capital Management, LLC | 379K | 0.88% | +220K | Aug 14, 2026 |
| Geode Capital | 265K | 0.62% | +28,850 | Aug 12, 2026 |